Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)

October 19, 2023 updated by: Yale University
The aim of this study is to examine the effect of social media intervention on the use of pre-exposure prophylaxis (PrEP) by young men who have sex with men (YMSM) in the greater New Haven area.

Study Overview

Detailed Description

There are three specific aims of this study. In the first specific aim, two focus group discussions (FGDs) of YMSM will be conducted to assess the feasibility and acceptability of social media intervention. In the second specific aim of the study, a quasi-pre-post experimental study will be conducted to examine the effect of social media intervention on PrEP uptake (primary outcome) and PrEP use intention, HIV testing, PrEP knowledge, self-efficacy and social support (secondary outcome). In the third specific aim of the study, the most important topics around PrEP will be assessed on the Facebook page of the intervention group by conducting a content analysis.

Study Type

Interventional

Enrollment (Actual)

227

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06510
        • Yale University
      • New Haven, Connecticut, United States, 06510
        • APNH: A Place to Nourish your Health (APNH)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 29 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Biologically male or transgender man
  • Self-identification as gay or bi-sexual
  • Resident of greater New Haven area
  • Willing and able to use Facebook during the span of the study

Exclusion Criteria:

  • • Women will not be included in the study

    • Under the age of 18 and over the age of 29
    • Unable to provide informed consent
    • Verbally or physically threatening to research staff

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PrEP Messages
The peer leaders and the study staff will post PrEP related health messages
The peer leaders and the study staff will post PrEP related health messages
Active Comparator: Health messages
The peer leaders and study staff will post general health messages that are not related to sexual health.
The peer leaders and study staff will post general health messages that are not related to sexual health

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PrEP uptake
Time Frame: PrEP uptake at baseline
Actual PrEP uptake: participants self report if they use prep (Yes/No)
PrEP uptake at baseline
PrEP uptake
Time Frame: PrEP uptake (Yes/No) at 24-weeks
Actual PrEP uptake: participants self report if they use prep (Yes/No)
PrEP uptake (Yes/No) at 24-weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HIV testing
Time Frame: baseline
Date of the last HIV test: participants self report the date of their last HIV test as a function of time in days.
baseline
HIV testing
Time Frame: 24-weeks
Date of the last HIV test: participants self report the date of their last HIV test as a function of time in days.
24-weeks
PrEP use intention
Time Frame: PrEP use intention at baseline
Willingness to use/likelihood of using PrEP in the next 6 months : self reported assessment to measure participants' willingness to use prep in the next 6 month s on a single question using Likert scale from 1(very unlikely) to 7 (very likely)
PrEP use intention at baseline
PrEP use intention
Time Frame: PrEP use intention at 24-weeks
Willingness to use/likelihood of using PrEP in the next 6 months : self reported assessment to measure participants' willingness to use prep in the next 6 month s on a single question using Likert scale from 1(very unlikely) to 7 (very likely)
PrEP use intention at 24-weeks
PrEP knowledge
Time Frame: PrEP knowledge at baseline
Knowledge of PrEP for HIV prevention: self reported assessment to measure participants' knowledge on PrEP on a set of True or False questions
PrEP knowledge at baseline
PrEP knowledge
Time Frame: PrEP knowledge at 24-weeks
Knowledge of PrEP for HIV prevention: self reported assessment to measure participants' knowledge on PrEP on a set of True or False questions
PrEP knowledge at 24-weeks
self efficacy to use PrEP
Time Frame: self efficacy to use PrEP at baseline
Beliefs in his/her ability of using PrEP: participants self report their level of confidence in taking PrEP on a set of items using Likert scales from 1 (Not at all confident) to 5 (completely confident)
self efficacy to use PrEP at baseline
self efficacy to use PrEP
Time Frame: self efficacy to use PrEP at 24-weeks
Beliefs in his/her ability of using PrEP: participants self report their level of confidence in taking PrEP on a set of items using Likert scales from 1 (Not at all confident) to 5 (completely confident)
self efficacy to use PrEP at 24-weeks
motivation to use PrEP
Time Frame: motivation to use PrEP at baseline
How motivated s/he is to use PrEP and what motivates s/he to use PrEP: self reported assessment to measure participants' different types of motivation to use PrEP on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)
motivation to use PrEP at baseline
motivation to use PrEP
Time Frame: motivation to use PrEP at 24-weeks
How motivated s/he is to use PrEP and what motivates s/he to use PrEP: self reported assessment to measure participants' different types of motivation to use PrEP on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)
motivation to use PrEP at 24-weeks
PrEP stigma
Time Frame: PrEP stigma at baseline
Perceived stigma related to PrEP use: self reported assessment to measure perception of stigma related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)
PrEP stigma at baseline
PrEP stigma
Time Frame: PrEP stigma at 24-weeks
Perceived stigma related to PrEP use: self reported assessment to measure perception of stigma related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)
PrEP stigma at 24-weeks
Social support for PrEP use
Time Frame: Social support for PrEP use at baseline
Help and support that individuals receive that can facilitate PrEP uptake: Perceived stigma related to PrEP use: self reported assessment to measure perception of social support related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)
Social support for PrEP use at baseline
Social support for PrEP use
Time Frame: Social support for PrEP use at 24-weeks
Help and support that individuals receive that can facilitate PrEP uptake: Perceived stigma related to PrEP use: self reported assessment to measure perception of social support related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)
Social support for PrEP use at 24-weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Frederick Altice, M.D., M.A., Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2018

Primary Completion (Actual)

April 1, 2023

Study Completion (Actual)

April 1, 2023

Study Registration Dates

First Submitted

June 2, 2020

First Submitted That Met QC Criteria

June 2, 2020

First Posted (Actual)

June 5, 2020

Study Record Updates

Last Update Posted (Actual)

October 23, 2023

Last Update Submitted That Met QC Criteria

October 19, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2000022728
  • 1H79TI080736 (Other Grant/Funding Number: Substance Abuse and Mental Health Services Administration)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All data will be kept confidential.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hiv

Clinical Trials on PrEP messages

3
Subscribe